CliffBio
small molecule

VANCOMYCIN HYDROCHLORIDE

VANCOMYCIN HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameVANCOMYCIN HYDROCHLORIDE
Active ingredientVANCOMYCIN HYDROCHLORIDE
StrengthEQ 250MG BASE
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalJune 2012
Marketing statusDISCN

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.